Observation of the Efficacy and Tolerance of Motens® (Lacidipine) in Patients With Essential Hypertension
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study of the efficacy and tolerance of Motens® (lacidipine) in patients with essential
hypertension. To obtain information on the dosage used in practice and the tolerance at the
start of treatment (12 weeks)